Electroconvulsive Therapy Shows Promise for Catatonia in SCN2A Variant Patient with Autism
No Comments on Electroconvulsive Therapy Shows Promise for Catatonia in SCN2A Variant Patient with Autism
An 18-year-old autistic patient with an SCN2A gene variant showed rapid catatonia remission after electroconvulsive therapy, highlighting potential treatment mechanisms involving cortical spreading depolarization.